> top > docs > PubMed:19749203 > spans > 251-369 > annotations

PubMed:19749203 / 251-369 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.
T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.
T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.
T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T5 73-78 FMAID:196724 denotes sugar

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 73-78 "http://rdf.glycoinfo.org/glycan/G59665TO" denotes sugar
GlycanIUPAC_T2 73-78 "http://rdf.glycoinfo.org/glycan/G32915EI" denotes sugar
GlycanIUPAC_T3 73-78 "http://rdf.glycoinfo.org/glycan/G60625TS" denotes sugar

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.
T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.
T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T3 0-118 Sentence denotes Earlier study suggested that LT-IIb bound preferentially to the terminal sugar sequence NeuAcalpha2-3Galbeta1-3GalNAc.